A roadmap for how a medicine can be priced at an annual cost equivalent to a house.
Reshared post from +BioTech Annecto
Inside The Pricing Of A $300,000-A-Year Drug
Inside The Pricing Of A $300,000-A-Year Drug – Forbes
Last night, NPS Pharmaceuticals announced that it was pricing Gattex, its drug for short bowel syndrome, at $295,000 per patient per year, about triple what analysts on Wall Street expected. It is the…
Google+: View post on Google+